Denying gender-affirming care to Medicaid recipients discriminates against low-income transgender youth

American policy and political debate over access to care, insurance coverage, costs, public programs and the regulation of medicine. Covers Medicare, Medicaid and the Affordable Care Act alongside drug pricing and the providers and insurers that sit between patients and treatment.

Coverage of the American economy and the policy that shapes it: inflation, employment, tariffs, taxation and the federal budget. Distinct from business news, which follows companies rather than the decisions taken in Congress and at the Federal Reserve.

Debate and legislation over how American government and public institutions treat gender identity, gender-affirming care and the rights of transgender people. Contested mainly at state level and in the courts, across schools, sports, healthcare access and the wording of identity documents.

A federal rule announced on 11 August bars Medicaid and CHIP money from paying for puberty blockers, hormones and surgery for minors. Roughly 130,000 transgender young people on those programs live in states where the care remains legal, and attorneys general in New York and Colorado have sued.